Literature DB >> 3377614

Low serum creatinine levels in severe hepatic disease.

T Takabatake1, H Ohta, Y Ishida, H Hara, Y Ushiogi, N Hattori.   

Abstract

For five years, eight patients had abnormally low serum concentrations of creatinine. All patients presented with severe hepatic failure, which was due to fulminant hepatitis in seven patients and to advanced primary biliary cirrhosis in one patients. The serum urate (as uric acid) concentration was also low in seven patients. Endogenous creatinine clearance was increased in all patients (2.38 to 14.75 mL/s [143 to 885 mL/min]). However, inulin clearance measured in four patients was reduced (25 to 32 mL/min) and the creatinine-to-inulin clearance ratio ranged from 4.5 to 9.9. This range can be explained largely by an increased tubular secretion of creatinine related to body fluid expansion caused by a large fluid infusion. Renal function would be extremely overestimated when assessed from serum concentrations or clearance of creatinine in such patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3377614

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  17 in total

1.  Evaluation of Vancomycin Dosing in Patients With Cirrhosis: Beginning De-Liver-ations about a New Nomogram.

Authors:  Randolph E Regal; Steven P Ren; Gregory Paige; Cesar Alaniz
Journal:  Hosp Pharm       Date:  2018-04-26

2.  Comparing age-wise reference intervals for serum creatinine concentration in a "Reality check" of the recommended cut-off.

Authors:  Mascha Verma; Rashmi Khadapkar; Priyadarshi Soumyaranjan Sahu; Bibhu Ranjan Das
Journal:  Indian J Clin Biochem       Date:  2006-09

Review 3.  Dose adjustment in patients with liver disease.

Authors:  Fabiola Delcò; Lydia Tchambaz; Raymond Schlienger; Jürgen Drewe; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Rapid estimation of creatinine clearances in patients with liver dysfunction.

Authors:  N P Lam; R Sperelakis; J Kuk; J D Seeger; A H Lau
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

5.  Serum sodium, renal function, and survival of patients with end-stage liver disease.

Authors:  Young-Suk Lim; Timothy S Larson; Joanne T Benson; Patrick S Kamath; Walter K Kremers; Terry M Therneau; W Ray Kim
Journal:  J Hepatol       Date:  2010-02-04       Impact factor: 25.083

6.  Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better?

Authors:  Jillian MacAulay; Kara Thompson; Bryce A Kiberd; David C Barnes; Kevork M Peltekian
Journal:  Can J Gastroenterol       Date:  2006-08       Impact factor: 3.522

7.  Decreased serum biochemical markers of muscle origin in patients with ankylosing spondylitis.

Authors:  E J Giltay; D van Schaardenburg; L J Gooren; P J Kostense; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  1999-09       Impact factor: 19.103

Review 8.  Renal dysfunction in chronic liver disease.

Authors:  Andy Slack; Andrew Yeoman; Julia Wendon
Journal:  Crit Care       Date:  2010-03-09       Impact factor: 9.097

Review 9.  Principles and clinical application of assessing alterations in renal elimination pathways.

Authors:  Susan E Tett; Carl M J Kirkpatrick; Annette S Gross; Andrew J McLachlan
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels.

Authors:  Dong Jin Kim; Hyun Seok Kang; Hyuk Soon Choi; Hye Jin Cho; Eun Sun Kim; Bora Keum; Hyonggin An; Ji Hoon Kim; Yeon Seok Seo; Yong Sik Kim; Hyung Joon Yim; Yoon Tae Jeen; Hong Sik Lee; Soon Ho Um; Chang Duck Kim; Ho Sang Ryu
Journal:  Korean J Hepatol       Date:  2011-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.